Q32 Bio Inc. - QTTB

Sector: Healthcare · Industry: Pharmaceutical Preparations

Website: No information yet · Social: No information yet

Company profile

Latest / Compare

Q1 2026 · Q4 2025

Value (USD)

Total reported value ($000)

$61.66M

QoQ value delta ($000)

+$35.02M (+131.46%)

Implied price effect (QoQ)

+90.92%

Total shares

9,752,050

QoQ shares delta

+1,708,140 (+21.24%)

Total shares held by funds (by quarter)

Interactive chart by TradingView.

Top 25 only Full list

Partial Q1 2026 data: 54 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.

Manager	Value ($000)	Shares	% of 13F
ORBIMED ADVISORS LLC	14,464	2,252,987	0.29%
Atlas Venture Life Science Advisors, LLC	13,431	2,092,106	1.7%
Opaleye Management Inc.	8,064	1,256,228	1.06%
Carlyle Group Inc.	7,079	1,102,741	0.07%
ARCH Venture Management, LLC	2,057	320,482	0.3%
ACORN CAPITAL ADVISORS, LLC	2,022	315,052	0.57%
VANGUARD CAPITAL MANAGEMENT LLC	1,967	306,401	0.0%
MACKENZIE FINANCIAL CORP	1,581	246,304	0.0%
Sanofi	1,567	244,083	0.47%
RENAISSANCE TECHNOLOGIES LLC	1,328	206,915	0.0%
ACADIAN ASSET MANAGEMENT LLC	1,106	172,586	0.0%
VANGUARD GROUP INC	1,065	321,051	0.0%
MONIMUS CAPITAL MANAGEMENT, LP	862	134,310	0.24%
GEODE CAPITAL MANAGEMENT, LLC	758	118,152	0.0%
PFIZER INC	736	101,618	0.31%
BlackRock, Inc.	553	86,147	0.0%
JANE STREET GROUP, LLC	421	65,599	0.0%
MARSHALL WACE, LLP	336	52,440	0.0%
VANGUARD FIDUCIARY TRUST CO	320	49,995	0.0%
TWO SIGMA INVESTMENTS, LP	271	42,346	0.0%
STATE STREET CORP	266	41,514	0.0%
Cambridge Investment Research Advisors, Inc.	225	35,025	0.0%
ADAR1 Capital Management, LLC	224	35,000	0.01%
Affinity Asset Advisors, LLC	178	27,777	0.01%
NORTHERN TRUST CORP	160	25,033	0.0%